Meeting Overview

Perspectives By:

Noel Allen
Vice President, Corporate Development
The Sun Products Corporation

Aris Chicles
Executive Vice President, Strategy
ITT Corporation

Ben Collins
Corp Development Product Marketing
IntraLinks

Nadia Damouni
Correspondent M&A
Reuters

Wesley Fredericks
Partner and Chair of the New York Corporate Practice
Jenner & Block

Greg Freeman
Vice President of Business Strategy & Development
Celanese

Randy Haase
Vice President Corporate Development, Mergers & Acquisitions
MetLife

Trace Harris
Senior Vice President, Strategy & Development - U.S.
Vivendi

Roth Kehoe
Partner, Corporate Finance and M&A
Hunton & Williams

Soyoung Kim
M&A Reporter
Reuters News

Courtney Leimkuhler
SVP, Co-Head of Corporate Strategy & Development
NYSE Euronext

Bob Little
VP Marketing
Innography

David Losch
Executive Director Mergers & Acquisitions
Sealed Air

Bob Mack
Vice President, Business Development
Ingersoll-Rand

Pradip Madan
SVP, Corporate Strategy
Synnex Corporation

Anne Madden
VP, Corporate Development & Global Head of M&A
Honeywell International

Fred Marcusa
Partner
Kaye Scholer

Geoffrey Martha
SVP Corporate Strategy & Business Development
Medtronic

Brian McDonagh
Managing Director, Co-Head of Mergers & Acquisitions
Robert W. Baird & Co.

David McGovern
Founder & Managing Partner
Marlin Equity Partners, LLC

Vipal Monga
Senior Editor
WSJ.com

John Paffenbarger
Vice President, Corporate Strategy and Development
Constellation Energy Group, Inc.

Kristin Peck
Executive Vice President Worldwide Business Development and Innovation
Pfizer

James Prevost
Vice President Corporate Acquisitions & Divestitures
Procter & Gamble

Julian Pritchard
Partner
Freshfields Bruckhaus Deringer

Marie Quintero-Johnson
Vice President & Director, Mergers & Acquisitions
Coca-Cola

Daniel Raskas
Sr VP Corp. Dev.
Danaher Corporation

Anton Sahazizian
Managing Director
Moelis & Company LLC

Roger Sawhney
SVP, Head of Global Corporate Strategy
Novartis

Naren Srinivasan
Vice President, Strategy and Corporate Development
Hertz

Cornell Stamoran
Vice President
Catalent Pharma Solutions

Aileen Stockburger
Vice President, Corporate Development
Johnson & Johnson

Jeffery Weirens
Principal and National Managing Director, Divestiture Services
Deloitte

Andrew Wilson
Partner
Deloitte


Summary:

Stability, certainty and confidence—the three vital behaviors that drove mergers and acquisitions to be erratic and elusive in 2011. Cash on corporate balance sheets remaining high, the availability of credit, and picking the right time to divest or acquire are ongoing concerns since the credit crisis. Amid these newer challenges, the evergreen issues of integration, internal management, strategic development and the risks of cross border M&A are still current. As the deal industry modifies its traditional practices, buyers and sellers continue to search for the next profitable business opportunity in 2012 as the challenging M&A market endures.

*Please note this meeting is off the record

Argyle meetings are by invitation only. If you did not receive an invitation but would like to inquire about attendance, please click here.

Registration is closed for this event

Date: Thursday, January 26, 2012

Time: 7:45am – 5:45pm

Location: New York, NY
*Event location will be disclosed to attendees upon completion of the registration process.

Advance registration is required for all member meetings. Registration is not available onsite.

To download the program from this member meeting please fill out the form below:

First Name


Last Name


Title


Company


Email


Phone number


back to top ↑